The Accessibility, Affordability, and Early Detection of Tuberculosis
DOI:
https://doi.org/10.47611/jsrhs.v13i2.6822Keywords:
Tuberculosis, Accessibility, Diagnosis, Clinical TrialsAbstract
Tuberculosis (TB) stands as the leading cause of death from an infectious agent worldwide, with a high fatality rate. It is primarily transmitted through the airborne Mycobacterium tuberculosis (M. tb) from an infected patient to a healthy individual. Annually, millions of people go undiagnosed for TB at an early stage and lose the opportunity for timely treatment, making early TB diagnosis a high priority. Prevalence surveys also have shown that many individuals with lab-confirmed TB disease lack symptoms and do not seek diagnosis or care. Moreover, delays in initiating treatment are commonly observed even after TB diagnosis, heightening the risk of disease transmission in the community. This research paper aims to address these challenges by analyzing the impact of various socioeconomic, policy, and healthcare factors on the accessibility of TB diagnosis. Furthermore, it aims to analyze current effective tuberculosis diagnosis techniques, assessing their strengths and weaknesses. Despite the presence of promising new drugs in the clinical trial stage offering hope for patients with extensively drug-resistant tuberculosis (XDR-TB) or very drug-resistant TB, the primary challenge remains the timely and species-specific detection of Tuberculosis. In addition to the detection of disease, identifying its drug resistance patterns and ensuring the availability of highly active short-course drug treatments are imperative, ideally lasting just a few weeks. This is essential to support the World Health Organization’s (WHO) Global efforts to “END TB” by 2030, to reach 90% of people primarily through early diagnosis, innovative treatments, and vaccine development.
Downloads
References or Bibliography
Acharya, V., Dhiman, G., Prakasha, K., Bahadur, P., Choraria, A., M, S., J, S., Prabhu, S., Chadaga, K., Viriyasitavat, W., & Kautish, S. (2022). AI-Assisted Tuberculosis Detection and Classification from Chest X-Rays Using a Deep Learning Normalization-Free Network Model. Computational intelligence and neuroscience, 2022, 2399428. https://doi.org/10.1155/2022/2399428
Aliannejad, R., Bahrmand, A., Abtahi, H., Seifi, M., Safavi, E., Abdolrahimi, F., & Shahriaran, S. (2016). Accuracy of a new rapid antigen detection test for pulmonary tuberculosis. Iranian journal of microbiology, 8(4), 238–242.
Georghiou, S. B., Alagna, R., Cirillo, D. M., Carmona, S., Rühwald, M., & Schumacher, S. G. (2021). Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection. PLOS ONE, 16(12), e0261442. https://doi.org/10.1371/journal.pone.0261442
Huddart, S., Asege, L., Jaganath, D., Golla, M. M., Dang, H. N., Lovelina, L., Derendinger, B., Andama, A., Christopher, D., Nhung, N. V., Theron, G., Denkinger, C. M., Nahid, P., Cattamanchi, A., & Yu, C. (2023). Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring. International Journal of Tuberculosis and Lung Disease, 27(3), 221–222. https://doi.org/10.5588/ijtld.22.0511
Mission Statement and Activities | About Us | TB | CDC. (n.d.). https://www.cdc.gov/tb/about/mission.htm#:~:text=To%20fulfill%20our%20mission%2C%20the,investigation%20%20and%20specialized%20periodic%20surveys
Pahar, M., Klopper, M., Reeve, B. W. P., Warren, R. M., Theron, G., & Niesler, T. (2021). Automatic cough classification for tuberculosis screening in a real-world environment. Physiological Measurement, 42(10), 105014. https://doi.org/10.1088/1361-6579/ac2fb8
Prasad, R. (2023, September 4). Chest X-ray interpretation using AI can detect more TB cases. The Hindu. https://www.thehindu.com/sci-tech/science/chest-x-ray-interpretation-using-ai-can-detect-more-tb-cases/article67259924.ece
Rapid sputum tests for tuberculosis (TB) | Kaiser Permanente. (n.d.). Kaiser Permanente. https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.rapid-sputum-tests-for-tuberculosis-tb.abk7483
Robotics, AI & ML. (n.d.-b). https://www.ipr.res.in/robotics_ai_ml.html
Roby, D. H. (2020). Evidence from early state Medicaid expansions demonstrates that uneven state implementation harms childless young adults. Journal of Adolescent Health, 67(3), 319–320. https://doi.org/10.1016/j.jadohealth.2020.06.028
Rosenbaum, S. (2011). The Patient Protection and Affordable Care Act: Implications for Public Health Policy and Practice. Public Health Reports, 126(1), 130–135. https://doi.org/10.1177/003335491112600118
Sharma, M., Nduba, V., Njagi, L. N., Murithi, W., Mwongera, Z., Hawn, T. R., Patel, S., & Horné, D. (2024). TBscreen: A passive cough classifier for tuberculosis screening with a controlled dataset. Science Advances, 10(1). https://doi.org/10.1126/sciadv.adi0282
Suda, C. (2023, October 25). Early Detection of Tuberculosis with Machine Learning Cough Audio Analysis: Towards More Accessible Global Triaging Usage. arXiv.org. https://arxiv.org/abs/2310.17675#:~:text=Cough%2C%20an%20objective%20biomarker%20for,where%20TB%20is%20most%20prevalent.
The Uninsured in Texas. (n.d.). https://www.texmed.org/uninsured_in_texas/#:~:text=Texas%20is%20the%20uninsured%20capital,623%2C000%20children%20%2D%20lack%20health%20insurance
Tuberculosis deaths. (2023, November 7). Our World in Data. https://ourworldindata.org/grapher/tuberculosis-deaths-who?tab=table
Tuberculosis: Totally drug-resistant TB. (n.d.). https://www.who.int/news-room/questions-and-answers/item/tuberculosis-totally-drug-resistant-tb
Tuberculosis (TB) - testing in BCG-Vaccinated persons. (2022, August 30). Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/testing/testingbcgvaccinated.htm#:~:text=A%20positive%20reaction%20to%20a,people%20who%20have%20received%20BCG.
TB Data and Statistics | Texas DSHS. (n.d.). https://www.dshs.texas.gov/tuberculosis-tb/tb-data-statistics
VinBrain and FIT utilizing AI in tuberculosis screening in Veitnam. (n.d.). https://biopharmaapac.com/news/77/248/vinbrain-and-fit-utilizing-ai-in-tuberculosis-screening-in-veitnam.html
World Health Organization: WHO & World Health Organization: WHO. (2023, November 7). Tuberculosis. https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Xiong, Y., Ba, X., Ao, H., Zhang, K., Chen, L., & Li, T. (2018). Automatic detection of Mycobacterium tuberculosis using artificial intelligence. Journal of Thoracic Disease, 10(3), 1936–1940. https://doi.org/10.21037/jtd.2018.01.91
Yenet, A., Nibret, G., & Tegegne, B. A. (2023). Challenges to the availability and affordability of essential medicines in African countries: a scoping review. ClinicoEconomics and Outcomes Research, Volume 15, 443–458. https://doi.org/10.2147/ceor.s413546
Zimmer, A. J., Ugarte-Gil, C., Pathri, R., Dewan, P., Jaganath, D., Cattamanchi, A., Pai, M., & Grandjean Lapierre, S. (2022). Making cough count in tuberculosis care. Communications Medicine, 2(1). https://doi.org/10.1038/s43856-022-00149-w
Published
How to Cite
Issue
Section
Copyright (c) 2024 Tanvi Kadiri; Dr.Kathryn Wilwohl, Prof. Virgel Torremocha, Jothsna Kethar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
